In some embodiments, the otic pharmaceutical formulation comprises about 52% by weight of the triglycerides
(Bethesda, MD: ClinicalTrials.gov) (2024)
The cohort included 15 cognitively healthy controls (HC), 17 patients with SCD, 14 patients with mild cognitive impairment (MCI), and 14 patients with dementia
If no reaction occurs, the product may be safe to use
Factors Affecting PT-141 Dosage Determining the appropriate dosage of PT-141 involves considering several factors that can influence its effectiveness and individual response
These symptoms can escalate to life-threatening difficulties for individuals with comorbidities such as type II diabetes, frailty, heart disease and general aging